Risk factors for the rising rates of primary liver cancer in the United States

Archives of Internal Medicine

Volumn 160, Issue 21, 2000, Pages 3227-3230

  El Serag, H B ^a   Mason, A C ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0034722741     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.21.3227     Document Type: Article

References (16)

1. Rising incidence of hepatocellular carcinoma in the United States
2. Statistical methods in cancer research
3. International Classification of Diseases for Oncology. 2nd ed.
4. Hepatocellular carcinoma
5. Hepatic tumors and cysts
6. Porymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen
7. Viral pathogenesis of hepatocellular carcinoma in the United States
8. Epidemiology of hepatitis C
9. Natural history of liver fibrosis progression in patients with chronic hepatitis C
10. Hepatitis C and hepatocellular carcinoma
11. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
12. Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis with cirrhosis
13. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis
14. Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan